Skip to main content
Journal cover image

Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome

Publication ,  Conference
De Beur, SJ; Miller, PD; Weber, TJ; Peacock, M; Insogna, KL; Kumar, R; Rauch, F; Luca, D; Theodore-Oklota, C; Lampl, K; Martin, JS; Carpenter, TO
Published in: JOURNAL OF BONE AND MINERAL RESEARCH
November 1, 2018

Duke Scholars

Published In

JOURNAL OF BONE AND MINERAL RESEARCH

EISSN

1523-4681

ISSN

0884-0431

Publication Date

November 1, 2018

Volume

33

Start / End Page

50 / 50

Location

Montreal, CANADA

Publisher

WILEY

Conference Name

Annual Meeting of the American-Society-for-Bone-and-Mineral-Research

Related Subject Headings

  • Anatomy & Morphology
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
  • 09 Engineering
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
De Beur, S. J., Miller, P. D., Weber, T. J., Peacock, M., Insogna, K. L., Kumar, R., … Carpenter, T. O. (2018). Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome. In JOURNAL OF BONE AND MINERAL RESEARCH (Vol. 33, pp. 50–50). Montreal, CANADA: WILEY.
De Beur, Suzanne Jan, Paul D. Miller, Thomas J. Weber, Munro Peacock, Karl L. Insogna, Rajiv Kumar, Frank Rauch, et al. “Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome.” In JOURNAL OF BONE AND MINERAL RESEARCH, 33:50–50. WILEY, 2018.
De Beur SJ, Miller PD, Weber TJ, Peacock M, Insogna KL, Kumar R, et al. Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome. In: JOURNAL OF BONE AND MINERAL RESEARCH. WILEY; 2018. p. 50–50.
De Beur, Suzanne Jan, et al. “Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome.” JOURNAL OF BONE AND MINERAL RESEARCH, vol. 33, WILEY, 2018, pp. 50–50.
De Beur SJ, Miller PD, Weber TJ, Peacock M, Insogna KL, Kumar R, Rauch F, Luca D, Theodore-Oklota C, Lampl K, Martin JS, Carpenter TO. Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome. JOURNAL OF BONE AND MINERAL RESEARCH. WILEY; 2018. p. 50–50.
Journal cover image

Published In

JOURNAL OF BONE AND MINERAL RESEARCH

EISSN

1523-4681

ISSN

0884-0431

Publication Date

November 1, 2018

Volume

33

Start / End Page

50 / 50

Location

Montreal, CANADA

Publisher

WILEY

Conference Name

Annual Meeting of the American-Society-for-Bone-and-Mineral-Research

Related Subject Headings

  • Anatomy & Morphology
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
  • 09 Engineering
  • 06 Biological Sciences